Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03314935 |
Title | A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Incyte Corporation |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | GBR | BEL |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Alabama | Birmingham | Alabama | 35294-3300 | United States | Details | |
USA Mitchell Cancer Center | Mobile | Alabama | 36604 | United States | Details | |
UC Davis - Comprehensive Cancer Centre | Sacramento | California | 95817 | United States | Details | |
Northwest Georgia Oncology Centers | Marietta | Georgia | 30060 | United States | Details | |
The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
START San Antonio | San Antonio | Texas | 78229 | United States | Details | |
Grand Hopital de Charleroi - Department of Medical Oncology | Brussels | 6000 | Belgium | Details | ||
Institut Jules Bordet - Clinical Trials Conduct Unit | Brussels | B-1000 | Belgium | Details | ||
UCL Cancer Institute | London | WC1E 6BT | United Kingdom | Details | ||
The Christie NHS Foundation Trust | Manchester | M20 4BX | United Kingdom | Details |